ヒトアルブミンの世界市場2016-2020

◆英語タイトル:Global Human Albumin Market 2016-2020
◆商品コード:IRTNTR9576
◆発行会社(調査会社):Technavio
◆発行日:2016年6月27日
◆ページ数:75
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:製薬
◆販売価格オプション(消費税別)
Single User(1名利用)USD2,500 ⇒換算¥277,500見積依頼/購入/質問フォーム
Five User(~5名利用)USD3,000 ⇒換算¥333,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD4,000 ⇒換算¥444,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。Technavio社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、ヒトアルブミンの世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、ヒトアルブミンの世界市場規模及び予測、用途別分析、地域別分析/市場規模、市場の成長要因、市場の課題、市場動向、競争状況などの情報をお届けいたします。
【レポートの概要】

About the Human Albumin Market
Albumin-based therapies such as Idelvion (CSL654 rIX-FP) by CSL Behring received marketing approval from the US FDA in March 2016 and from the EMA in May 2016. Apart from these, Albutropin (TV-1106) by Teva Pharmaceuticals, Ampion by Ampio Pharmaceuticals, and Albutein by Grifols (for Alzheimer’s disease) are expected to enter the market during the forecast period.

The demand for albumin is high in APAC in countries like India and China. Still, the uptake of these therapeutics is less due to the lack of awareness about these products and their therapeutic uses. Thus, the awareness programs conducted by organizations such as PPTA, which includes International Plasma Awareness Week, to help increase the awareness about plasma donation and the different plasma protein therapies available, along with their potential uses, is expected to increase the uptake of these therapeutics in treating various conditions.

Technavio’s analysts forecast the global human albumin market to grow at a CAGR of 4.97% during the period 2016-2020.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global human albumin market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of branded and generic albumin drugs used to treat infections, liver diseases, shock, during surgery, and severe burns. The report also considers the revenues to be generated from the sales of drugs that are expected to be launched in the market along with the decline in revenues from the genericization of the marketed drugs during the forecast period.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Human Albumin Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• CSL Behring
• Grifols
• Baxalta
• Octapharma
• Kedrion

[Other prominent vendors]
• AADi
• Ablynx
• Albumedix
• Ampio Pharmaceuticals
• Azaya Therapeutics
• Beijing Tiantan
• Biotest
• Bristol-Myers Squibb
• Celgene
• ConjuChem
• GSK
• Hebei Changshan Biochem Pharma
• HiMedia Laboratories
• Hualan Biological Engineering
• InVittria
• MedxBio
• Merck
• Mitsubishi Tanabe Pharma
• NantBioScience
• Novo Nordisk
• Novozymes
• Shanghai RAAS Blood Products
• Sucampo Pharmaceuticals
• Teva Pharmaceuticals
• Thermo Fisher Scientific
• Tianjin SinoBiotech & Beijing Bio-Fortune
• Ventria Bioscience
• Yoshitomi Pharmaceutical

[Market driver]
• High demand for human albumin in China
• For a full, detailed list, view our report

[Market challenge]
• Spread of pathogenic contaminants
• For a full, detailed list, view our report

[Market trend]
• Rise in non-therapeutic applications
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

※You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【レポートの目次】

PART 01: Executive summary
• Highlights

PART 02: Scope of the report
• Market overview
• Top-vendor offerings

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights

PART 05: Plasma therapeutics: An overview
• Components of blood plasma
• Derivation of various plasma therapeutics

PART 06: Global plasma therapeutics market
• Market overview
• Market size and forecast

PART 07: Plasma fractionation market
• Overview
• Market size and forecast
• Market players

PART 08: Albumin: An overview
• Types of albumin
• Albumin in human body
• Clinical uses

PART 09: Pipeline portfolio

PART 10: Global albumin market

PART 11: Market landscape
• Global human albumin market
• Five forces analysis

PART 12: Market segmentation by application
• Replacement therapy
• Drug formulation and delivery
• Vaccine ingredients
• Others

PART 13: Geographical segmentation
• Global human albumin market by geographical segmentation 2015-2020
• Human albumin market in APAC
• Human albumin market in Americas
• Human albumin market in EMEA

PART 14: China albumin market
• Plasma therapeutics market in China
• Human albumin market in China

PART 15: Market drivers
• High demand for human albumin in China
• Exploitation of new therapeutic indications
• Increase in production capacity

PART 16: Impact of drivers

PART 17: Market challenges
• High cost of therapy
• Spread of pathogenic contaminants
• High regulations in the market

PART 18: Impact of drivers and challenges

PART 19: Market trends
• Novel technologies for albumin-based drug development
• Rise in non-therapeutic applications
• Increased development of recombinant albumin

PART 20: Vendor landscape
• Competitive scenario
• Market analysis 2015
• CSL Behring
• Grifols
• Baxalta
• Octapharma
• Kedrion
• Other prominent vendors

PART 21: Appendix
• List of abbreviations

PART 22: Explore Technavio

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Blood plasma composition
Exhibit 03: Plasma proteins composition by percentage share
Exhibit 04: Total number of plasma donations in US 2010-2014
Exhibit 05: Projected global YoY growth and fractionation capacity of manufacturing units (millions of liter/annum)
Exhibit 06: Process of derivation of AAT from plasma
Exhibit 07: Global plasma therapeutics market 2015-2020 ($ billions)
Exhibit 08: Segmentation of plasma-derived products on revenue 2015
Exhibit 09: Global plasma fractionation market 2015-2020 ($ billions)
Exhibit 10: Line of treatment of albumin in various diseases
Exhibit 11: Pipeline portfolio: Albumin-based therapeutics
Exhibit 12: Segmentation of global albumin market
Exhibit 13: Global human albumin market 2015-2020 ($ billions)
Exhibit 14: Global human albumin market 2015-2020 (tons)
Exhibit 15: Five forces analysis
Exhibit 16: Segmentation of human albumin market based on application
Exhibit 17: Segmentation of global human albumin market based on geography 2015
Exhibit 18: Human albumin market revenue by geography 2015-2020 ($ billions)
Exhibit 19: Human albumin market by geography 2015-2020
Exhibit 20: Human albumin market in APAC 2015-2020 ($ billions)
Exhibit 21: Albumin market in China in global albumin market 2015
Exhibit 22: Human albumin market in Americas 2015-2020 ($ billions)
Exhibit 23: Albumin market in US 2015
Exhibit 24: Human albumin market in EMEA 2015-2020 ($ millions)
Exhibit 25: Global human albumin market: YoY growth and revenue based on geography 2015-2020
Exhibit 26: Segmentation of various plasma products 2015
Exhibit 27: Plasma therapeutics market in China 2015-2020 ($ billions)
Exhibit 28: Human albumin market in China 2015-2020 ($ billions)
Exhibit 29: Domestic and imported albumin in China 2015
Exhibit 30: Impact of drivers
Exhibit 31: Impact of drivers and challenges
Exhibit 32: CSL Behring: Segmentation by revenue 2015
Exhibit 33: CSL Behring: YoY revenue and growth rate of albumin products 2013-2015 ($ millions)
Exhibit 34: CSL Behring: Key takeaways
Exhibit 35: Grifols: YoY growth rate and revenue of bioscience segment 2013-2015 ($ billions)
Exhibit 36: Grifols: Key takeaways
Exhibit 37: Baxalta: Segmentation by revenue 2015
Exhibit 38: Baxalta: YoY revenue comparison of Biotherapeutics segment 2013-2015 ($ millions)
Exhibit 39: Baxalta: Geographic segmentation of BioTherapeutics 2015
Exhibit 40: Baxalta: Key takeaways
Exhibit 41: Octapharma: Key takeaways
Exhibit 42: Kedrion: Key takeaways



【掲載企業】

CSL Behring, Grifols, Baxalta, Octapharma, Kedrion, AADi, Ablynx, Albumedix, Ampio Pharmaceuticals, Azaya Therapeutics, Beijing Tiantan, Biotest, Bristol-Myers Squibb, Celgene, ConjuChem, GSK, Hebei Changshan Biochem Pharma, HiMedia Laboratories, Hualan Biological Engineering, InVittria, MedxBio, Merck, Mitsubishi Tanabe Pharma, NantBioScience, Novo Nordisk, Novozymes, Shanghai RAAS Blood Products, Sucampo Pharmaceuticals, Teva Pharmaceuticals, Thermo Fisher Scientific, Tianjin SinoBiotech & Beijing Bio-Fortune, Ventria Bioscience, Yoshitomi Pharmaceutical.

【レポートのキーワード】

ヒトアルブミン、治療、医薬品、ワクチン、 ヒトアルブミン用途

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[ヒトアルブミンの世界市場2016-2020]販売に関する免責事項
★調査レポート[ヒトアルブミンの世界市場2016-2020]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆